22
OCTOBER 2012 Interesting Case 1

Interesting Case 1

  • Upload
    carlo

  • View
    52

  • Download
    0

Embed Size (px)

DESCRIPTION

Interesting Case 1. October 2012. Interesting Case 1. View the following cytology images and then think about your diagnosis. Slides 12 onwards provide the answer and follow up with corresponding histology. Case submitted by. - PowerPoint PPT Presentation

Citation preview

Page 1: Interesting Case 1

OCTOBER 2012

Interesting Case 1

Page 2: Interesting Case 1

Interesting Case 12

View the following cytology images and then think about your diagnosis.

Slides 12 onwards provide the answer and follow up with corresponding histology

Page 3: Interesting Case 1

Case submitted by3

Nick Dudding FIBMS, Advanced Biomedical Scientist Practitioner, Sheffield, UK. Assistant Director. East Pennine Cytology Training Centre.

Callum Bowler FIBMS. Advanced Biomedical Scientist Practitioner. James Cook University Hospital. Middlesbrough. UK

Page 4: Interesting Case 1

Case history4

67 year old Female. SurePath™ LBC sampleModified Papanicoloau stainingAll photomicrographs are x 400

Page 5: Interesting Case 1

5 Figure 1.

Page 6: Interesting Case 1

6 Figure 2.

Page 7: Interesting Case 1

7 Figure 3.

Page 8: Interesting Case 1

8Figure 4.

Page 9: Interesting Case 1

9 Figure 5.

Page 10: Interesting Case 1

10 Figure 6.

Page 11: Interesting Case 1

What do you think this represents ?

11

Tissue repairClear cell carcinomaDecidual changeSquamous cell carcinomaCarcinosarcoma (mixed Müllerian carcinoma)

The answer is on the next page

Page 12: Interesting Case 1

Answer12

It is ECarcinosarcoma or mixed Müllerian

carcinoma

Page 13: Interesting Case 1

Cytomorphology13

Figure 1 shows one exfoliated ball of cells with slightly eccentric nuclear placement and prominent nucleoli. This would represent the carcinomatous elements.

Figure 2 shows a single, but highly abnormal looking cell with multiple nucleoli contained within two enlarged nuclei.

The remaining figures show a variety of enlarged or elongated cells, all with nucleoli, but also presenting with plentiful cyanophilic cytoplasm. These almost certainly represent the sarcomatous elements.

Page 14: Interesting Case 1

Histopathology14

The uterus showed a high grade carcinosarcoma composed predominantly of sarcoma (Figures b – c) with rhabdomyoblasts and a minor component of serous adenocarcinoma (Figure a).

The carcinosarcoma infiltrated a leiomyoma, but not the myometrium and hence is best regarded as FIGO IB. Focal vascular invasion was seen. The cervix, omentum and right and left ovaries and tubes showed no significant histological abnormalities.

Page 15: Interesting Case 1

15 Figure A.

Page 16: Interesting Case 1

16 Figure B.

Page 17: Interesting Case 1

17 Figure C.

Page 18: Interesting Case 1

Disease Fact Sheet 18

Malignant mixed Müllerian tumor, also known as malignant mixed mesodermal tumor, MMMT and carcinosarcoma, is a malignant neoplasm arising in the uterus.(1)

Although MMMT can be picked up by cytology it generally presents in a postmenopausal patient being investigated for uterine bleeding, and found to have an enlarged uterus

Page 19: Interesting Case 1

Disease Fact Sheet19

They are usually large, soft polypoid tumours occuring in the endometrium and myometrium. They are composed of a mixture of carcinomatous and sarcomatous elements. (2,3)

• The appearance of the sarcomatous elements divides the entity into two types, homologus and heterologous. In the homologous type, the sarcomatous component resembles tissues found in the uterus such as endometrial stromal sarcoma or leiomyosarcoma. In the heterologous type the sarcomatous element comprises tissues not found in the uterus, such as cartilage, skeletal muscle and/or bone.

Page 20: Interesting Case 1

Disease Fact Sheet20

MMMT account for between two and five percent of all tumors derived from the body of the uterus, and are found predominantly in postmeonopausal women with an average age of 66 years.(4)

Risk factors are similar to those of adenocarcinomas and include obesity, exogenous estrogen therapies, and nulliparity. Less well-understood but potential risk factors include tamoxifen therapy and pelvic irradiation(5)

Page 21: Interesting Case 1

Disease Fact Sheet21

Outcome of MMMTs is determined primarily by depth of invasion and stage. As with endometrial carcinomas, the prognosis is influenced by the grade and type of the adenocarcinoma, being poorest with serous differentiation. MMMTs are highly malignant; a stage I tumor has an expected five-year survival rate of 50%, while the overall five-year survival rate is less than 20%.[5]

Page 22: Interesting Case 1

22

References

1. Barwick KW, Livolski VA. Malignant mixed Müllerian tumours of the uterus. Am J Surg Pathol 1979, 3: 125 – 135.

2. Silverberg SG, Major FJ,Blessing JA, Fetter B, Askin FB, Liao sy, Miller A. Carcinosarcoma (malignant mixed mesodermal tumour

3. A gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol1990, 9: 647 – 651.

4. Chuang JT, Van Velden DJJ, Graham JB Carcinosarcoma and mixed mesodermal tumour of the uterine corpus. Review of 49 cases. Obstet Gynecol 1970, 35: 769 -780.

5. Siegal GP; Chhieng DC (2005). Updates in diagnostic pathology. Berlin: Springer. pp. 12-14. ISBN 0-387-25357-2.